FDA Import Refusal 739-7034304-9/1/1 — Xellia Pharmaceuticals ApS
The FDA refused shipment 739-7034304-9/1/1 from Xellia Pharmaceuticals ApS (Denmark) on August 4, 2016. The refused product falls under Drugs and Biologics — COLISTIN SULFATE (PEPTIDES). Cited charge: 118 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- August 4, 2016
- Country
- Denmark
- Product Category
- Drugs and Biologics
- Product Code
- 56FCS21 COLISTIN SULFATE (PEPTIDES)
- Charges
- 118